Santhosh Girirajan
Santhosh GirirajanAffiliated Investigator

Santhosh Girirajan, MBBS, PhD, is an Associate Professor of Genomics in the Department of Biochemistry and Molecular Biology and of Anthropology at Pennsylvania State University. His research is focused on untangling the genetic and phenotypic heterogeneity associated with neurodevelopmental disorders by combining human genetics, computational genomics, and functional genomics using model systems.

Daniel Moreno De Luca
Daniel Moreno De LucaAffiliated Investigator

Daniel Moreno De Luca, MD MSc, is an Assistant Professor at the Division of Child and Adolescent Psychiatry within the Department of Psychiatry and Human Behavior at the Warren Alpert Medical School of Brown University. He is also the Clinical Director of the Genomic Psychiatry Consultation Service at Bradley Hospital, and Principal Investigator at the Precision Medicine in Autism (PRISMA) Group. He received his MD from the Universidad Industrial de Santander in Colombia, his MSc in Neuroscience from the Pierre et Marie Curie – Sorbonne Université in France, followed by postdoctoral training in Neurogenetics at Emory University, Psychiatry Residency at Yale University, and Child and Adolescent Psychiatry Fellowship at Brown University. His research and clinical care focus on understanding the impact of rare genetic changes on neurobehavioral phenotypes, especially autism and other developmental disorders, and implementing Precision Medicine strategies in psychiatry. He currently has NIMH funding to characterize the psychiatric and medical phenotypes of people with 17q12 CNVs, and to identify additional common genetic variation that may influence the expression of such phenotypes. He and his team work closely with the 17q12 Foundation, and with international collaborators to establish a research, clinical, and community network for families with 17q12 CNVs, and had the privilege of hosting the most recent International 17q12 Family Conference at Brown University.

Jennifer Mulle
Jennifer MulleAffiliated Investigator

Jennifer Mulle, MHS, PhD, is an Associate Professor in the Departments of Psychiatry and Neuroscience and Cell Biology at the Robert Wood Johnson School of Medicine, Rutgers University, and a member of the Rutgers Center for Genomics of Psychiatric Health and Addictions and the Rutgers Brain Health Institute.

Dr. Mulle’s research program aims to understand the developmental progression of schizophrenia and related neurodevelopmental and psychiatric disorders at the molecular, cellular, circuitry, and behavioral scales of analysis. She uses rare genetic variants as models for this area of inquiry with a focus on the schizophrenia-associated 3q29 deletion. Dr. Mulle is the leading expert on the phenotypic spectrum of 3q29 deletion syndrome, and her lab supports the 3q29 registry housed at Rutgers University. She also maintains the 3q29 repository of human 3q29 deletion samples as well as the 3q29 mouse model. Dr. Mulle works closely with the 3q29 deletion stakeholder community on outreach, engagement, and education.

Dr. Mulle earned her MHS in genetic epidemiology at the Johns Hopkins School of Public Health, and her PhD in Human Genetics from the Johns Hopkins School of Medicine. She completed postdoctoral training in the lab of Dr. Steven Warren at Emory University, where she discovered the association of the 3q29 deletion with high risk for schizophrenia.